You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
一图看懂诺辉健康(06606.HK)IPO
格隆汇 02-04 19:10

中国癌症早筛第一股诺辉健康(06606.HK)2021年2月5日-2月10日招股,预计2月18日上市。公司拟全球发售7659.8万股,其中香港发售766万股占10%,国际发售6893.8万股占90%,另有15%超额配股权;发行区间为22.70港元-26.66港元,每手买卖单位500股,入场费约13464.33港元;高盛和瑞银为联合保荐人。

格隆汇APP获悉,诺辉健康是中国癌症筛查市场的先行者和领导者,公司旗下两款结直肠癌筛查产品已获国家药品监督管理局的批准并正式开始商业化,常卫清是中国首个且目前唯一一个获得国家药品监督管理局批准的癌症早筛产品。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account